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ABSTRACT
Scaffolds mimicking structural and chemical characteristics of the 
native bone tissues are critical for bone tissue engineering. Herein, 
we have developed and characterized epigallocatechin gallate/
duck’s feet collagen/hydroxyapatite (EGCG/DC/HAp) composite 
sponges that enhanced the bone tissue regeneration. The three-
dimensional composite sponges were synthesized by loading various 
amounts (i.e. 1, 5 and 10 μM) of EGCG to duck feet derived collagen 
followed by freeze-drying and then coating with hydroxyapatite. 
Several measuremental techniques were employed to examine 
the properties of the as-fabricated composite sponges including 
morphology and structure, porosity, compressive strength, etc. 
and as well compared with pristine duck feet derived collagen. SEM 
observations of EGCG/DC/HAp sponges showed the formation of a 
highly porous collagen matrix with EGCG embodiment. The porosity 
and pore size of sponges were found to increase by high EGCG 
content. The compressive strength was calculated as 3.54  ±  0.04, 
3.63 ± 0.03, 3.89 ± 0.05, 4.047 ± 0.05 MPa for 1, 5 and 10 μM EGCG/DC/
HAp sponges, respectively. Osteoblast-like cell (BMSCs isolated from 
rabbit) culture and in vivo experiments with EGCG/DC/HAp sponges 
implanted in nude mouse followed by histological staining showed 
enhanced cell internalization and attachment, cell proliferation, 
alkaline phosphatase expressions, indicating that EGCG/DC/HAp 
sponges have ahigh biocompatibility. Moreover, highEGCG content 
in the EGCG/DC/HAp sponges have led to increased cellular behavior. 
Collectively, the 5 μM of EGCG/DC/HAp sponges were suggested as 
the potential candidates for bone tissue regeneration.
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1. Introduction
Bone tissue engineering plays an important role in treating human bone defect mostly 
caused by traffic accidents, innate disease or acquired disease [1]. Scaffolds portray a crucial 
role in bone tissue engineering because of their efficient capability of mimicking bone extra-
cellular matrix (ECM) functions. Native bone ECM is a 3D porous and organic-inorganic 
composite materials that supporting cellular adhesion, differentiation and further growth. 
The organic phase includes collagen and non-collagenous proteins, sulfated and non-sul-
fated glycosaminoglycans, whereas the mineral phase of bone comprises semi-crystalline 
carbonated hydroxyapatite capable of standing against compressive load [2]. Hence, the 
selection of ideal biomaterial for tissue-engineered constructs are crucial to guide cells into 
functional tissue via improving cell adhesion, proliferation and differentiation.
We choose a naturally derived polymer, duck’s feet collagen with good cell seeding and 
cell attachment and rapid biodegradation [3,4]. The fabrication method and biocompatibility 
of duck’s feet collagen were already evaluated in our previous study [5,6]. Moreover, DC 
has been widely used as a base material for tissue-engineered bone constructs previously, 
as well many studies reported the incorporation of various osteo-inductive elements i.e. 
bone growth factors and cytokines [7–9]. However, studies regarding to the usage of plant/
herbal extracts for bone regeneration are scanty. Approximately 25% of available drugs 
which are allowed to prescript were derived from plants, trees, and herbs [10]. Inspired by 
those medicinal values, we have employed epigallocatechin gallate (EGCG) which is the 
most abundant catechin found in green tea, onion and apple skin, contributing to various 
beneficial health effects associated with their consumption [11–14]. EGCG, known as epigal-
locatechin-3-gallate, is an ester of epigallocatechin and gallic acid, and is a type of catechin 
[15]. Previous reports have shown that EGCG in combination with α-tricalcium phosphate 
particles can stimulate bone regeneration by increasing the formation of mineralized bone 
nodules with human osteoblast-like cells [16]. We hypothesize that EGCG usage, as a nature 
derived biomaterial for bone tissue regeneration instead of growth factors and cytokines, 
not only reduce scaffold’s cost and risk, but also provide medicinal benefits.
MSC exist in almost all tissues including bone marrow, adipose tissue, cartilage. They 
have the ability to migrate into sites of injury and differentiated toward terminally com-
mitted cells for use in regenerative medicine. Bone marrow stromal stem cells (BMSCs) 
possess the capability of self-renewed and differentiation into organ-specific cell types. Due 
to excellent proliferation and immunologic characteristics BMSCs appear to be ideal seeding 
cells. The cell population harvested from bone marrow cells in various conditioned media 
can make specific cell phenotype and amounts available for graft construction.
The main aim of our study is to design an efficient bone graft that promotes bone growth 
in the bone defect region via inducing BMSCs proliferation and differentiation. In this study, 
we have fabricated epigallocatechin gallate/duck’s feet collagen/hydroxyapatite (EGCG/
DC/HAp) composite sponges as a function of EGCG contents (i.e. 1, 5 and 10 μM) via 
freeze-drying for enhanced bone tissue regeneration. The efficiency of the EGCG/DC/HAp 
composite sponges were evaluated for osteogenic differentiation of BMSCs in both in vitro 
and in vivo environments. Physiological, chemical, thermal and mechanical characteristics 
of the sponges were examined using scanning electron microscopy and Fourier transform 
infrared spectroscopy (FTIR).
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2. Materials and methods
2.1. Materials
For this study, Raw Duck’s feet were purchased from Korean local market. EGCG, sodium 
hydroxide, chloroform, acetone, methanol, citric acid, pepsin, and acetic acid were obtained 
from Sigma-Aldrich. All reagents used in this experiment were high-performance liquid 
chromatography (HPLC) grade.
2.2. Preparation of duck’s feet collagen
Duck’s feet collagen (DC) was prepared according to our previously reported study [17]. 
In brief, iced duck’s feet was washed with distilled water and immersed in 0.5 M sodium 
hydroxide solution for 24 h to remove fat from tissue followed by washing with methanol: 
chloroform solution in 3:1 ratio, acetone, alcohol and distilled water, respectively. For col-
lagen extraction, the feet were again submerged in 5% citric acid for 24 h and then mixed 
with 3 g pepsin for 48 h. Then the supernatant was collected. To obtain precipitated DC, 
the supernatant was centrifuged at 10,000 rpm for 10 min, filtered with gauze and centri-
fuged at 3500 rpm with ethanol. Finally, the obtained products were lyophilized. Prior to 
the fabrication of composite sponges, the lyophilized DC was added to 0.5 M acetic acid 
and stirred for 3 days (2% DC solution).
2.3. Fabrication of EGCG/DC/HAp sponges
The EGCG/DC sponges were prepared using the freeze-drying method. First, 10 μM EGCG 
was prepared in distilled water under stirring at 60 rpm for 30 min. Different concentra-
tionof (1, 5 , 10 μM) EGCG solution poured into 2% collagen solution in exact quantity. 
The collagen solution loaded EGCG was then poured into 48 well plate (1 mL/well) and 
frozenat −80 °C, thawed at room temperature at an interval of 6 h for three times. Next, 
the EGCG/DC/HAp sponges were prepared according to the following method: dried 2% 
EGCG/DC sponges were immersed in 1.0X stimulated body fluid (SBF) solution for 24 h, 
washed in distilled water and lyophilized for 48 h.
2.4. Sponges characterizations
The sponges’ morphology were examined by SEM. The chemical properties of sponges were 
analyzed by Fourier transform infrared spectroscopy (FTIR, Spectrum GX, Perkin Elmer, 
USA) in the range of 4000–500 cm−1. The compressive mechanical strength and height 
of the sponges were measured by TMS-Pro instrument (Food Technology Corporation, 
Sterling, VA, USA) where the samples were moved down at a target distance to specimen 
of 1.5 mm with a speed of 10 mm/s and force of 0.5 N.
2.5. Isolation and culture of bone marrow derived mesenchymal stem cells
BMSCs were isolated from New Zealand White rabbits (6  weeks old, female). Briefly, 
bone marrow was harvested from the tibia and femur condyle. BMSCs were isolated from 
bone marrow by ficoll density-gradient centrifugation. Then, the BMSCs were plated in 
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alpha-minimum essential culture medium (α-MEM) (Lonza, Walkersville, MD, USA) con-
taining 20% fetal bovine serum, and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA, 
USA) at 37 °C and 5% CO2. The culture medium was replaced in every third day. BMSCs 
were seeded into each sponge at a concentration of 1 × 10⁵ cells.
2.6. In vitro cell proliferation
Prior to cell seeding experiments, the sponges were sterilized with 70% ethanol about 
30 min, removed ethanol with phosphate buffer saline (PBS) about 20 min and hydrated 
with α-MEM in the incubator. Then, passage 1 BMSCs were detached from the dishes and 
seeded into the sponges at a density of 1 × 105/sponges. After culturing of the cells on EGCG/
DC/HAp sponges for 7 and 28 days, the sponges were washed with PBS and fixed with 2.5% 
SEM-grade glutaraldehyde (diluted in 1X PBS) for 24 h at room temperature. The samples 
were dehydrated using series of ethanol solutions (increasing from 50 to 100%). Finally, the 
images were observed by SEM (SN-SUPRA 40VP, Carl Zeiss, Germany).
The cell proliferation on the sponges were measured using MTT (3-4-2, 5-diphenyl 
tetrazolium bromide, Sigma-Aldrich, USA) assay. In brief, BMSCs were seeded on the 
as-prepared sponges for 1, 7, 14 and 21 days. One hundred milliliter of MTT solution was 
added to the sponges and incubated for 4 h at 37 °C and 5% CO₂. After the formation of 
purple crystals, the solution was removed and sponges were carefully washed with PBS. One 
microliter of dimethylsulfoxide (DMSO, Sigma-Aldrich) was added and incubated for 24 h. 
One hundred milliliter of the solution was pipetted into 96-well plate, and the absorbance 
was noted at 570 nm using Synergy Mx monochromator-based multi-mode microplate 
reader (Biotek instruments, Inc., USA).
2.7. Alkaline phosphatase activity
The osteogenic differentiation of BMSCs on sponges were measured with ALP Assay Kit 
(Takara Bio Inc., Tokyo, Japan) according to the manufacture’s protocol. BMSCs were seeded 
in the sponges at the concentration of 5 × 10⁴/sponge and cultured in culture medium for 1, 
7, 14 and 21 days. At each time point, the samples were rinsed with PBS. The protein from 
each BMSCs seeded with sponge extracted using 5% alkaline phosphatase (ALP) extraction 
solution, and added para-nitrophenyl phosphate (pNPP) solution. The reaction solution 
incubated at 37 °C and 5% CO2 for 1 h. The reaction was stopped by adding 0.9 N NaOH 
stop solution. The absorbance was measured at 405 nm using microplate reader (Biotek 
instruments, Inc., USA).
2.8. Real-time polymerase chain reaction
Further, osteogenic gene expression was evaluated by reverse transcription polymerase 
chain reaction (RT-PCR). After 1, 7, 14 and 21 days of cell culture in sponges, total RNA 
was extracted using a Trizol reagent (Takara Bio Inc., Tokyo, Japan) and 0.2 mL chloro-
form. The supernatants precipitated with 0.5 mL of isopropanol (Sigma-Aldrich) and 5 μL 
of Polyacryl Carrier (Molecules Research Center, Inc., Cincinnati, OH, USA). The RNA 
samples were reverse transcribed into cDNA using Oligo (dT) primer (Invitrogen™), each 
of primers; Glyceraldehyde 3-phosphate dehydrogenase (GAPDH), type-I collagen (Col-I), 
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and osteocalcin (OCN). We observed that all PCR products were separated by electropho-
resis on 1.2% (w/v) agarose gel containing ethidium bromide (EtBr) which was visualized 
under UV light (FluorChem HD2 Gel Imaging System, Alpha Innotech) at 300 nm. The 
primers used in this study were purchased from Genotec (Daejon, Korea).
2.9. Histological evaluation
Histological evaluation of bone tissue differentiation was performed after 2 and 4 weeks 
post-surgery. For implantation, we sterilized sponges. In the clean bench, the sponge was 
placed in a 24well plate according to each experiment group (n = 3). To sterilize sponges, 
1 ml of 70% alcohol was placed in a well plate containing sponge for 30 min under UV lamp. 
Then, remove the 70% alcohol and rinsed it 2 times in PBS solution for 20 min. Lastly, PBS 
was removed and alpha mem medium was placed in a well plate containing sponges then 
incubation before BMSCs seeding.
BMSCs seeded sponges were implanted into the subcutaneous armpit of four weeks old 
athymic nude mouse (100–150 g, female, Hanil laboratory animal center, Korea). Nude 
mice were anesthetized with intramuscular injection with 150 μL of Zoletil (Virbac S. A, 
FRA) and Domitor (Orion Pharma, FIN) by ratio of 2:1. The surgical site was washed with 
povidone-iodone. Cell-sponge constructs were implanted into the subcutaneous dorsum 
of nude mouse (n = 2 per each group, 20 mice). Then the implants were harvested after 2 
and 4 weeks. All experiment procedures were performed with the approval of the Chonbuk 
National University Animal Care Committee, Jeonju, Korea (CBNU 2016-50).
Subsequently, the collected implants were fixed in 10% formaldehyde (Sigma-Aldrich), 
dehydrated with a series of graded ethanol, and specimens were embedded in paraffin. 
Paraffin sections of 8-μm thickness were conducted by microtome (Thermo Scientific) and 
fixed on poly-L-lysine (PLL) coating slide. Sections were stained with hematoxylin and 
eosin (H&E) and von kossa after the de-paraffin process for histological examination. All 
the samples were analyzed under an optical microscope.
2.10. Statistical analysis
The data were expressed as means ± Standard Deviation (SD) of experiments performed in 
triplicate. Statistical significance was analyzed using Student’s t-test and p values less than 
0.05 is accepted to indicate statistically significant differences.
3. Result and discussion
3.1. Morphology of EGCG/DC/HAp sponges
Figure 1 showed the (a) gross and (b) cross-sectional images of DC/HAp, and 1, 5 and 10 μM 
EGCG/DC/HAp composite sponges. All the sponges presented a similar elliptical shape 
and a smooth, soft and sponge-like morphology along with thickness of 2 mm and wide 
length of ~7 mm. These uniform elliptical shapes can be ascribed to the 3 h refrigeration, 
freeze- drying and lyophilization [18].
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3.2. Mechanical properties
Figure 2 showed the (a) FTIR spectra, (b) compressive strength, and (c) porosity of bare 
DC/HAp and 1, 5 and 10 μM EGCG/DC/HAp sponges. The FTIR spectrum (Figure 2(a)) 
of 2% DC displayed several characteristic peaks at 1780 and 900 cm−1, ascribed to amide-I 
and amide-II. The hydroxyapatite spectrum showed peaks at 1114 and 1002 cm−1, assigned 
to P–O phosphate groups stretching of three, and peaks at 968 and 943 cm−1 were attributed 
to P–O bonds banding modes in the phosphate groups. Moreover, the FTIR spectra of HAp 
showed well-preserved characteristic peaks within the DC/HAp sponges [19], thus suggest-
ing that no significant structural changes of DC/HAp throughout the composite formation. 
Further EGCG/DC/HAp sponges’ spectrum showed all DC/HAp and EGCG defined peaks, 
which further intensified with an increase in EGCG contents. According to the porosity 
results (Figure 2(c)), DC/HAp, 1  μM EGCG/DC/HAp, 5  μM EGCG/DC/HAp sponges 
showed 52.27 ± 3.12, 47.35 ± 5.53, 55.02 ± 5.07, 60.42 ± 2.94%, respectively. The mechan-
ical properties of the sponges were studied by measuring compression strength of sponges 
(Figure 2(b)). The samples showed 3.54 ± 0.04, 3.63 ± 0.03, 3.89 ± 0.05, 4.047 ± 0.05 MPa 
for DC/HAp and EGCG/DC/HAp sponges. The addition of EGCG was found to improve 
the compressive strength of the EGCG/DC/HAp sponges as compared to DC/HAp sponge.
3.3. Osteogenic differentiation of BMSCs on DC/HAp and EGCG/DC/HAp sponges
The osteogenic differentiation of BMSCs on DC/HAp and EGCG/DC/HAp composite 
sponges were evaluated by culturing BMSCs on the sponges and examined by SEM obser-
vation, MTT assay and ALP assay. The SEM images (Figure 3) displayed the interconnected 
Figure 1. (a) Gross images, and (b) cross-section sem image of as-fabricated 1, 5 and 10 μm eGcG/dc/
Hap sponges.
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pores sponges. The interconnected pores are critical for transporting essential nutrients, 
oxygen to cells and removal of cell debris. The architecture of micro-periodic construct has 
been reported to enhance the bone regeneration in vivo [20]. The morphology of cultured 
BMSCs on EGCG/DC/HAp composite sponges was noticed after 7 and 28 days. The mor-
phology of BMSCs on both DC/HAp and EGCG/DC/HAp sponges showed round shape 
and osteoblastic-like morphology in the pores surrounded by ECM on 7th day of culture. 
Compared to the EGCG/DC/HAp sponges, DC/HAp sponges displayed a very few cells. 
Interestingly, significantly high number of cells were especially surrounded in the 5 μM 
EGCG/DC/HAp sponges on day 28, thus these results suggesting that the EGCG compound 
efficiency for supporting cell proliferation and attachment.
Figure 4 showed the osteogenic differentiation of BMSCs on cultured on 1, 5 and 10 μM 
EGCG/DC/HAp sponges for 1, 7, 14, 21 and 28 days studied by MTT assay and ALP assay. 
The MTT assay (Figure 4(a)) was performed at 1, 7, 14, and 21 days of BMSCs culturing to 
evaluate the cell proliferation on DC/HAp and EGCG/DC/HAp sponges. Until 7 days of 
cell culture, no significant difference was observed between DC/HAp and EGCG/DC/HAp 
sponges. However, on 14th and 21st day, the 5 μM of EGCG/DC/HAp sponge showed higher 
cell proliferation rate than the bare DC/HAp and 1, 10 μM EGCG/DC/HAp sponges. This 
result indicates that the potency of EGCG content present in EGCG/DC/HAp sponges for 
promoting cell attachment and proliferation. Furthermore, the osteogenic differentiation of 
Figure 2. (a) ftir spectra, (b) Porosity, and (c) compressive strength of 1, 5 and 10 μm eGcG/dc/Hap 
sponges (n = 3).
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BMSCs on 1, 5 and 10 μM EGCG/DC/HAp sponges were also confirmed by ALP assay, as 
shown in Figure 4(b). At 1st and 7th day of cell culture, the ALP activity of BMSCs showed 
no significant difference between bare DC/HAp and EGCG/DC/HAp sponges. Presenting 
a consistency with the MTT assay, the cultured BMSCs on 5 μM EGCG/DC/HAp sponges 
demonstrated higher ALP activity on 14th and 21st day.
Figure 3. sem images of Bmscs cultured on the as-fabricated 1, 5 and 10 μm eGcG/dc/Hap sponges for 
21 days, showing enhanced cell attachment and proliferation (n = 3).
Figure 4. osteogenic differentiation of Bmscs on cultured on 1, 5 and 10 μm eGcG/dc/Hap sponges for 
1, 7, 14, 21 and 21 days studied by (a) mtt assay and (b) alP assay (n = 3 in each group, p*<0.05).
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3.4. RT-PCR analysis
To study the ability of osteogenic differentiation of BMSCs on DC/HAp and EGCG/DC/HAp 
sponges, qRT-PCR was performed to detect the expressions of bone-specific genes such as 
OCN, RUNX-2 and COL1 after 21 days cell culture and GAPDH was used to normalized 
the data as shown in Figure 5(a) and (b). OCN plays an important role in pro-osteoblast 
and bone formation. RUNX-2 gene was associated with osteoblast differentiation [21]. 
COL1 also plays an important role in producing osteoblast and depositing mineral [22]. 
Compared with the gene expression on bare DC/HAp sponges, gene expression was showed 
upregulated evidently for EGCG/DC/HAp sponges. Notably, real-time quantitative (RQ) 
values of OCN (1.47994), RUNX-2 (1.8794) and COL1 (0.88362) on the 5 μM EGCG/DC/
HAp sponges displayed highest expressions. Its suitability for further in vivo studies was 
confirmed by the in vitro studies indicated the favorable effects of EGCG on BMSCs oste-
ogenic differentiation and ECM mineralization. Thus biological evaluation qualifies of the 
5 μM EGCG/DC/HAp sponges as a potential construct for bone tissue regeneration. EGCG 
at concentrations of 1 and 5 μM caused a dose-dependent increase expression as assessed 
by gel image. But 10 μM is decreased expression compared other experiment groups. This 
because excessive addition of EGCG suppressed osteoblast maturation by inhibiting late-
stage differentiation [23]. It may partially contribute to the supressive effects of EGCG on 
osteodifferentiation.
Figure 5. mrna expression of Bmscs analyzed by rt-Pcr on 21 days. (a) electrophoresis assay using 
specific cell markers. (b) normalization by GaPdH (n = 3 in each group, p* < 0.05).
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3.5. Histological analysis
The in vivo osteoinduction and osteoconduction ability of the as-fabricated DC/HAp and 
EGCG/DC/HAp sponges were examined by implanting the sponges on a full thickness 
the subcutaneous region of athymic nude mice followed by their sacrifice at 2 and 4 weeks 
post-surgery for staining experiments. Figure 6 showed the histological evaluation of EGCG/
DC/HAp sponges implanted under the subcutaneous region of athymic nude mice for 2 
and 4 weeks using hematoxylin and eosin (H&E). Compared to the DC/HAp sponges, H&E 
staining results displayed denser stains and thicker bone matrix for the EGCG/DC/HAp 
sponges. Moreover, the 5  μM EGCG/DC/HAp sponges showed well-defined construct, 
higher osteoblast infiltration and distribution among the EGCG/DC/HAp sponges. Figure 
7(a) showed the histological evaluation of EGCG/DC/HAp sponges implanted under the 
subcutaneous region of athymic nude mice for 2 and 4 weeks stained using Von Kossa. 
The intensity of the dark brown-black dye of von Kossa implies calcium deposition in the 
sponges [24]. The part that can be seen in black is the part where the mineral is depos-
ited (HA) in the scaffolds, and the bone cell is exist around it. Compared with the DC/
HAp sponges, the EGCG/DC/HAp sponges displayed higher staining intensity and cal-
cium deposition. Noteworthy, we observed a highest Von Kossa staining intensity for the 
5 μM EGCG/DC/HAp sponges, consistent with the H&E staining results. The proportion of 
Figure 6. Histological evaluation of eGcG/dc/Hap sponges implanted under the subcutaneous region 
of athymic nude mice for 2 and 4 weeks stained hematoxylin and eosin(H&e) (×40 maginification, n = 3 
in each group, p*<0.05) (Please see the online article for the colour version of this figure: https://doi.org/ 
10.1080/09205063.2017.1414480).
note: red arrow – bone mineralized nodule; blue arrow – osteoblast.
JOURNAL OF BIOMATERIALS SCIENCE, POLYMER EDITION  11
calcium deposition to area was plotted by the Image J program Figure 7(b). When compar-
ing the mean percentage of Von Kossa values of 2 and 4 weeks, DC/HAp is 14.585 ± 0.023, 
33.984 ± 0.132, 1 μM EGCG/DC/HAp is 30.799 ± 0.1423, 33.984 ± 0.132, 5 μM EGCG/
DC/HAp is 43.817 ± 0.4332, 49.159 ± 0.1323 and 10 μM EGCG/DC/HAp is 26.048 ± 0.412, 
31.64 ± 0.313 respectively. EGCG at concentrations of 1 and 5 μM caused a dose-dependent 
increase in the number and area of mineralized bone nodules as assessed by Von Kossa. 
But 10 μM is lower value comparing 1 and 5 μM EGCG/DC/Hap. This result that excessive 
addition of EGCG was found to down regulates osteoblast maturation by inhibiting late-
stage differentiation [25].
4. Conclusions
We have fabricated DC/HAp, 1, 5, and 10  μM EGCG/DC/HAp sponges to evaluate its 
efficiency as potential scaffold for healing bone defects and stimulating bone regeneration. 
The sponges displayed an increased mechanical strength owing to more compact, dense 
pores and high compressive strength as added EGCG to the DC/HAp sponges. The EGCG/
DC/HAp sponges also demonstrated improved cell viability and osteoinduction, since the 
presence of EGCG in the sponges have significantly up-regulated expression of osteogenic 
genes and the formation of bone-like nodules. Further exploration has indicated that EGCG 
directs osteogenic differentiation via the continuous up-regulation of Runx2, OCN, COL 
Figure 7. (a) Von Kossa stained section of eGcG/dc/Hap sponges (×100). (b) evaluation of Von Kossa 
staining demonstrating calcium deposition within eGcG/dc/Hap sponges (n = 2).
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1 on 1 and 5 μM EGCG/DC/HAp. We identified by H&E and Von Kossa staining. H&E 
staining results show well-defined construct and cell distribution in all experiment groups. 
As a result of the H&E staining, after 2 weeks, there was space but after 4 weeks It was 
confirmed that there was osteoblast in the space of the empty sponge and we indicate 
osteoblast. In particular, the 5 μM EGCG/DC/HAp sponges significantly increased bone 
mineralized nodules. Through Von Kossa staining, the calcium deposition part that can be 
seen in dark brown is the part where the mineral is deposited (HAp) in the scaffolds, and 
the bone cell is exist around it.
And particularly, 5 μM EGCG/DC/HAp sponge is more brownish and has a larger dark 
brown area than the other three groups. This suggests that the osteoblast are more present 
in the 5 μM EGCG/DC/HAp sponge. Collectedly, the EGCG/DC/HAp sponge with good 
physical properties, enhanced cell proliferation may promote the osteogenic differentiation 
of rBMSCs and act as a chemoattractant to drive bone regeneration. And it could be applied 
to the human body substitute as a natural material for bone regeneration.
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